Joel Ackerman is the CEO of DaVita Inc. He holds a Bachelor's degree in Economics from the University of Pennsylvania and has a solid background in finance. Before joining DaVita in February 2017, he was the CEO of Champions Oncology,...

Joel Ackerman is the CEO of DaVita Inc. He holds a Bachelor's degree in Economics from the University of Pennsylvania and has a solid background in finance. Before joining DaVita in February 2017, he was the CEO of Champions Oncology, where he worked on developing advanced technology for cancer treatments. He also co-founded Guidon Partners, a private equity firm that focuses on healthcare services. Joel has a notable past as a managing director at Warburg Pincus, which is a global private equity firm. He was heavily involved in the healthcare industry and has served on various boards, including Kindred Healthcare. Joel's journey through these roles shows his deep understanding of both corporate finance and healthcare. He’s not just about leading; he’s about strategy and growth, often balancing cash and stock options in his pay structure to align his interests with the company's success. A sign-on bonus of $200,000 when he joined DaVita indicates the company's confidence in his abilities to steer the business forward.